PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine, Clinical Research Center, Faculty of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran.\', \'Department of Clinical Pharmacy, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.\', \'Department of Orthopedic Surgery, Faculty of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran.\', \'Student Research Committee, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.\', \'XB20 Drug Design, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands.\', \'Department of Chemistry, Faculty of Science, Shahid Rajaee Teacher Training University, Tehran, Iran.\', \'Department of Surgery, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran.\', \'Baqiyatallah Hospital, Baqiyatallah University of Medical Sciences, Tehran, Iran.\', \'Pharmacognosy Research Laboratories and Herbal Analysis Services, School of Science, University of Greenwich, Kent, UK.\', \'Department of Clinical Pharmacy, Medical Toxicology and Drug Abuse Research Center (MTDRC), Faculty of Pharmacy, Birjand University of Medical Sciences, Birjand, Iran.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/jcpt.13251
?:doi
?:hasPublicationType
?:journal
  • Journal of clinical pharmacy and therapeutics
is ?:pmid of
?:pmid
?:pmid
  • 32860252
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.722
?:rankingScore_hIndex
  • 61
is ?:relation_isRelatedTo_publication of
?:title
  • Neutrophil elastase inhibitor (sivelestat) may be a promising therapeutic option for management of acute lung injury/acute respiratory distress syndrome or disseminated intravascular coagulation in COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all